Rocket Pharmaceuticals (RCKT) Goodwill (2018 - 2026)

Rocket Pharmaceuticals has reported Goodwill for 9 years, with the latest figure at $39.2 million in Q1 2026.

• Quarterly Goodwill changed 0.12% year-over-year to $39.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.2 million (changed 0.12% YoY) and the FY2025 annual result came in at $39.2 million, changed 0.0% from the prior year.
• Goodwill was little changed at $39.2 million in Q1 2026 per RCKT's latest filing, from $39.2 million in the prior quarter.
• Over five years, Goodwill peaked at $39.2 million in Q4 2022 and troughed at $30.8 million in Q1 2022.
• A 5-year average of $37.7 million and a median of $39.2 million in 2023 frame the typical range for Goodwill.
• The sharpest annual moves came in 2022 and 2026: Goodwill grew 27.21% in 2022, then retreated 0.12% in 2026.
• Over 5 years, Goodwill stood at $39.2 million in 2022, then changed by 0.0% to $39.2 million in 2023, then changed by 0.0% to $39.2 million in 2024, then changed by 0.0% to $39.2 million in 2025, then fell by 0.12% to $39.2 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $39.2 million, $39.2 million, and $39.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.